Demographic and Clinical Predictors of Helicobacter pylori Infection in Symptomatic Patients From Middle Eastern Countries: A Systematic Review and Meta-Analysis
Main Article Content
Abstract
Background: Helicobacter pylori infection remains common in symptomatic populations, but prevalence and associated clinical, endoscopic, and socioeconomic factors vary across Middle Eastern settings. This review estimated pooled prevalence and summarized factor-specific associations with H. pylori positivity. Methods: PubMed, Web of Science, Google Scholar, and Semantic Scholar were searched through 1 June 2026 for observational studies involving symptomatic adult or pediatric patients tested for H. pylori. Prevalence was synthesized using a random-effects model. Clinical, endoscopic, demographic, socioeconomic, and environmental factors were evaluated as separate associations rather than combined into category-wide summary effects. Methodological quality was assessed using the Joanna Briggs Institute checklist. Results: Eleven studies comprising 10,814 participants with assessable H. pylori status were included. Pooled prevalence was 37.62% (95% CI 27.02–48.21%), with substantial heterogeneity (I²=99%). Positive clinical associations included abdominal pain, anorexia, pallor/low hemoglobin, weight loss, and hematemesis; vomiting showed a large but highly imprecise estimate. Endoscopic associations included antral nodularity, gastric and duodenal erosions, duodenal ulcer, gastritis, mosaic gastritis, and esophagitis/GERD. Environmental and socioeconomic associations included daycare/community contact, large household size, illiteracy, bed sharing, low income, street-food consumption, unsafe water supply, and overcrowding. Conclusion: H. pylori infection is common but heterogeneous among symptomatic regional populations. Several clinical, endoscopic, and socioeconomic factors are associated with positivity, but these observational associations should not replace guideline-recommended diagnostic testing. Keywords: Helicobacter pylori; Prevalence; Dyspepsia; Associated Factors; Endoscopic Findings; Socioeconomic Factors; Middle East
Article Details
Issue
Section

This work is licensed under a Creative Commons Attribution 4.0 International License.
How to Cite
References
1. The sequence below reconciles the revised Introduction → Methods → Results → Discussion. Previously cited sources retain their assigned numbers, while references first introduced in the Discussion continue from 22 onward.
2. Malfertheiner P, Camargo MC, El-Omar E, Liou JM, Peek R, Schulz C, et al. Helicobacter pylori infection. Nat Rev Dis Primers. 2023;9(1):19. doi:10.1038/s41572-023-00431-8.
3. Li Y, Choi H, Leung K, Jiang F, Graham DY, Leung WK. Global prevalence of Helicobacter pylori infection between 1980 and 2022: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2023;8(6):553-564. doi:10.1016/S2468-1253(23)00070-5.
4. Yuan C, Adeloye D, Luk TT, Huang L, He Y, Xu Y, et al. The global prevalence of and factors associated with Helicobacter pylori infection in children: a systematic review and meta-analysis. Lancet Child Adolesc Health. 2022;6(3):185-194. doi:10.1016/S2352-4642(21)00400-4.
5. Alsulaimany FAS, Awan ZA, Almohamady AM, Koumu MI, Yaghmoor BE, Elhady SS, et al. Prevalence of Helicobacter pylori infection and diagnostic methods in the Middle East and North Africa region. Medicina (Kaunas). 2020;56(4):169. doi:10.3390/medicina56040169.
6. Sabbagh P, Mohammadnia-Afrouzi M, Javanian M, Babazadeh A, Koppolu V, Vasigala VR, et al. Diagnostic methods for Helicobacter pylori infection: ideals, options, and limitations. Eur J Clin Microbiol Infect Dis. 2019;38(1):55-66. doi:10.1007/s10096-018-3414-4.
7. Hasosah M, Satti M, Shehzad A, Alsahafi A, Sukkar G, Alzaben A, et al. Prevalence and risk factors of Helicobacter pylori infection in Saudi children: a three-year prospective controlled study. Helicobacter. 2015;20(1):56-63. doi:10.1111/hel.12172.
8. Galal YS, Ghobrial CM, Labib JR, Abou-Zekri ME. Helicobacter pylori among symptomatic Egyptian children: prevalence, risk factors, and effect on growth. J Egypt Public Health Assoc. 2019;94:17. doi:10.1186/s42506-019-0017-6.
9. Naushad VA, Purayil NK, Badi A, Chandra P, Abuzaid HO, Abuhmaira MM, et al. Potential predictors and prevalence of Helicobacter pylori infection among adult patients with dyspepsia: a retrospective study from Qatar. Cureus. 2021;13(7):e16216. doi:10.7759/cureus.16216.
10. Hojati SA, Kokabpeyk S, Yaghoubi S, Joukar F, Asgharnezhad M, Mansour-Ghanaei F. Helicobacter pylori infection in Iran: demographic, endoscopic and pathological factors. BMC Gastroenterol. 2021;21:355. doi:10.1186/s12876-021-01931-1.
11. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi:10.1136/bmj.n71.
12. Munn Z, Moola S, Lisy K, Riitano D, Tufanaru C. Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data. Int J Evid Based Healthc. 2015;13(3):147-153. doi:10.1097/XEB.0000000000000054.
13. Higgins JPT, Migliavaca C, Buitrago-García D, Munn Z. Systematic reviews of prevalence: challenges and future steps. JBI Evid Synth. 2025. doi:10.11124/JBIES-25-00487.
14. Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539-1558. doi:10.1002/sim.1186.
15. Review Manager (RevMan) [Computer program]. Version 5.4. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration; 2020.
16. Türkölmez S, Derya C, Füsun A, Meliha K. The relationship of Helicobacter pylori positivity with age, sex, and ABO/Rhesus blood groups in patients with gastrointestinal complaints in Turkey. Helicobacter. 2007;12(3):244-250. doi:10.1111/j.1523-5378.2007.00500.x.
17. Alazmi WM, Siddique I, Alateeqi N, Al-Nakib B. Prevalence of Helicobacter pylori infection among new outpatients with dyspepsia in Kuwait. BMC Gastroenterol. 2010;10:14. doi:10.1186/1471-230X-10-14.
18. Alshaikh S, Al Sharakhat A, Toorani Z, Farid E, Abdulla M. Prevalence and diagnosis of Helicobacter pylori infection in a tertiary hospital in the Kingdom of Bahrain. Bahrain Med Bull. 2021;43(3):547-550.
19. Ismail MB, Osman M, Bou Raad E, Achkar M, Hamze M. Seroprevalence of Helicobacter pylori among dyspeptic patients in northern Lebanon: a 6-year retrospective study in two tertiary hospitals. Access Microbiol. 2022;4:000337. doi:10.1099/acmi.0.000337.
20. Saeed AY, Rashad BH, Ali BN, Sulaivany AH, Ibrahim KS. Helicobacter pylori infection: prevalence, risk factors, and treatment efficacy in symptomatic patients in Zakho City, Kurdistan Region, Iraq. Cureus. 2024;16(11):e73873. doi:10.7759/cureus.73873.
21. Boutari R, Zayour N, Hmedeh AN, Bashashi DK, Assaf F, Al Tahan J, et al. Prevalence, risk factors, and endoscopic findings of Helicobacter pylori infection among Lebanese patients undergoing gastroscopy: a retrospective study from a single tertiary center. Antibiotics (Basel). 2025;14(10):1013. doi:10.3390/antibiotics14101013.
22. Abdulridha HO, Aziz ZS, Ibrahim KS. Prevalence and predictors of Helicobacter pylori infection in Maysan Governorate, Iraq. Egypt J Med Microbiol. 2026;35(3):in press.
23. Hooi JKY, Lai WY, Ng WK, Suen MMY, Underwood FE, Tanyingoh D, et al. Global prevalence of Helicobacter pylori infection: systematic review and meta-analysis. Gastroenterology. 2017;153(2):420-429. doi:10.1053/j.gastro.2017.04.022.
24. Zamani M, Ebrahimtabar F, Zamani V, Miller WH, Alizadeh-Navaei R, Shokri-Shirvani J, et al. Systematic review with meta-analysis: the worldwide prevalence of Helicobacter pylori infection. Aliment Pharmacol Ther. 2018;47(7):868-876. doi:10.1111/apt.14561.
25. Malfertheiner P, Megraud F, Rokkas T, Gisbert JP, Liou JM, Schulz C, et al. Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report. Gut. 2022;71(9):1724-1762. doi:10.1136/gutjnl-2022-327745.
26. Chey WD, Howden CW, Moss SF, Morgan DR, Greer KB, Grover S, et al. ACG Clinical Guideline: Treatment of Helicobacter pylori Infection. Am J Gastroenterol. 2024;119(9):1730-1753. doi:10.14309/ajg.0000000000002968.
27. Brown LM. Helicobacter pylori: epidemiology and routes of transmission. Epidemiol Rev. 2000;22(2):283-297. doi:10.1093/oxfordjournals.epirev.a018040.
28. Aziz RK, Khalifa MM, Sharaf RR. Contaminated water as a source of Helicobacter pylori infection: a review. J Adv Res. 2015;6(4):539-547. doi:10.1016/j.jare.2013.07.007.
29. Ibrahim A, Morais S, Ferro A, Lunet N, Peleteiro B. Sex-differences in the prevalence of Helicobacter pylori infection in pediatric and adult populations: systematic review and meta-analysis of 244 studies. Dig Liver Dis. 2017;49(7):742-749. doi:10.1016/j.dld.2017.03.019.